Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology

Similar Items

• Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
  by: Francis A.; Wainstein M.; Irish G.; Abdul Hafidz M.I.; Chen T.; Cho Y.; Htay H.; Kanjanabuch T.; Lalji R.; Neuen B.L.; See E.; Shah A.; Smyth B.; Tungsanga S.; Viecelli A.; Yeung E.K.; Arruebo S.; Bello A.K.; Caskey F.J.; Damster S.; Donner J.-A.; Jha V.; Johnson D.W.; Levin A.; Malik C.; Nangaku M.; Okpechi I.G.; Tonelli M.; Ye F.; Wong M.G.; Bavanandan S.; Abdul Gafor A.H.; Amouzegar A.; Bennett P.; Chicano S.L.; Davids M.R.; Davison S.N.; Diongole H.M.; Divyaveer S.; Ekrikpo U.E.; Ethier I.; Fong V.K.; Fung W.W.-S.; Ghimire A.; Gopal B.; Phan H.A.H.; Harris D.C.H.; Houston G.; Ibrahim K.S.; Jardine M.J.; Jindal K.; Kantachuvesiri S.; Kelly D.M.; Kerr P.; Kim S.; Krishnasamy R.; Kwek J.L.; Lee V.; Liew A.; Lim C.Y.; Lydia A.; Nalado A.M.; Olanrewaju T.O.; Osman M.A.; Petrova A.; Pyar K.P.; Riaz P.; Saad S.; Sakajiki A.M.; Sengthavisouk N.; Sozio S.M.; Srisawat N.; Tan E.; Tiv S.; Tomacruz Amante I.D.; Villanueva A.R.; Walker R.; Walker R.; Zaidi D.
  Published: (2024)
• Author Correction: Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions (Nature Reviews Nephrology, (2022), 18, 11, (724-737), 10.1038/s41581-022-00618-4)
  by: Geetha D.; Kronbichler A.; Rutter M.; Bajpai D.; Menez S.; Weissenbacher A.; Anand S.; Lin E.; Carlson N.; Sozio S.; Fowler K.; Bignall R.; Ducharlet K.; Tannor E.K.; Wijewickrama E.; Hafidz M.I.A.; Tesar V.; Hoover R.; Crews D.; Varnell C.; Danziger-Isakov L.; Jha V.; Mohan S.; Parikh C.; Luyckx V.
  Published: (2022)
• Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
  by: Geetha D.; Kronbichler A.; Rutter M.; Bajpai D.; Menez S.; Weissenbacher A.; Anand S.; Lin E.; Carlson N.; Sozio S.; Fowler K.; Bignall R.; Ducharlet K.; Tannor E.K.; Wijewickrama E.; Hafidz M.I.A.; Tesar V.; Hoover R.; Crews D.; Varnell C.; Danziger-Isakov L.; Jha V.; Mohan S.; Parikh C.; Luyckx V.
  Published: (2022)
• Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|
  by: Francis A.; Abdul Hafidz M.I.; Ekrikpo U.E.; Chen T.; Wijewickrama E.; Tannor E.K.; Nakhoul G.; Wong M.M.Y.; Pereira-Kamath N.; Chanchlani R.; Kalyesubula R.; Karam S.; Kumar V.; Calice-Silva V.; Jha V.
  Published: (2022)
• Shear wave elastography in chronic kidney disease – the physics and clinical application
  by: Ng K.H.; Wong J.H.D.; Leong S.S.
  Published: (2024)